Evanston, IL, United States of America

Jeffrey D Brodin

This inventor holds 1 USPTO granted patent and 17 published patent applications and 1 EPO patent. Top assignee: Northwestern University. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jeffrey D Brodin

Introduction

Jeffrey D Brodin is an accomplished inventor based in Evanston, Illinois. He has made significant contributions to the field of therapeutics through his innovative work on core-shell nanoparticles. His research focuses on the development of advanced therapeutic solutions that leverage the unique properties of these nanoparticles.

Latest Patents

Jeffrey D Brodin holds a patent for "Protein/oligonucleotide core-shell nanoparticle therapeutics." This patent encompasses core-shell nanoparticles, compositions that include these nanoparticles, and methods for their application in therapeutic settings. His work represents a significant advancement in the field of nanomedicine.

Career Highlights

Brodin is affiliated with Northwestern University, where he continues to engage in groundbreaking research. His academic and professional journey has been marked by a commitment to innovation and excellence in the field of therapeutic development.

Collaborations

One of his notable collaborators is Chad A Mirkin, a prominent figure in the field of nanotechnology. Their partnership has contributed to the advancement of research in nanoparticle applications.

Conclusion

Jeffrey D Brodin's work exemplifies the intersection of innovation and therapeutic development, showcasing the potential of core-shell nanoparticles in medicine. His contributions continue to influence the field and inspire future research endeavors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…